Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLN1202 in relapsing-remitting multiple sclerosis
NCT01199640Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- May 2005
- Primary completion
- Jul 2007
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of plozalizumab in relapsing-remitting multiple sclerosis (RRMS), sponsored by Millennium Pharmaceuticals. Started May 2005; status: completed.
02
Drugs
plozalizumab
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01199640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199640.